Shihai Lu
About
Shihai Lu is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Economics and Econometrics.
According to data from OpenAlex, Shihai Lu has authored 24 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cardiology and Cardiovascular Medicine, 5 papers in Internal Medicine and 3 papers in Economics and Econometrics. Recurrent topics in Shihai Lu's work include Atrial Fibrillation Management and Outcomes (23 papers), Cardiac Arrhythmias and Treatments (16 papers) and Antiplatelet Therapy and Cardiovascular Diseases (8 papers). Shihai Lu is often cited by papers focused on Atrial Fibrillation Management and Outcomes (23 papers), Cardiac Arrhythmias and Treatments (16 papers) and Antiplatelet Therapy and Cardiovascular Diseases (8 papers). Shihai Lu collaborates with scholars based in Netherlands, United Kingdom and United States. Shihai Lu's co-authors include Menno V. Huisman, Jonathan L. Halperin, Christine Teutsch, Hans‐Christoph Diener, Gregory Y.H. Lip, Sérgio Dubner, Miney Paquette, Kenneth J. Rothman, Kristina Zint and Lionel Riou França and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and PLoS ONE.
In The Last Decade
Shihai Lu
22 papers receiving 347 citations
Peers
Shihai Lu
Anja Katholing Australia
Gloria Kayani United Kingdom
Steve Deitelzweig United States
Lauren Uyeda United States
Peter J Svensson Sweden
Alan John Camm United Kingdom
Franziska Ebertz Germany
Volkan Doğan Türkiye
Gheorghe‐Andrei Dan Romania
C.V. Damaraju United States
Citations per year, relative to Shihai Lu Shihai Lu (= 1×)
peers
Anja Katholing
Countries citing papers authored by Shihai Lu
Since
Specialization
Citations
This map shows the geographic impact of Shihai Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shihai Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shihai Lu more than expected).
Fields of papers citing papers by Shihai Lu
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Shihai Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shihai Lu. The network helps show where Shihai Lu may publish in the future.
Co-authorship network of co-authors of Shihai Lu
This figure shows the co-authorship network connecting the top 25 collaborators of Shihai Lu. A scholar is included among the top collaborators of Shihai Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shihai Lu. Shihai Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Lu, Shihai, Lionel Riou França, Gregory Y.H. Lip, et al.. (2022). Evolution of antithrombotic therapy for patients with atrial fibrillation: The prospective global GLORIA-AF registry program. PLoS ONE. 17(10). e0274237–e0274237.
2.
Huisman, Menno V., Christine Teutsch, Shihai Lu, et al.. (2022). Dabigatran versus vitamin K antagonists for atrial fibrillation in clinical practice: final outcomes from Phase III of the GLORIA-AF registry. Clinical Research in Cardiology. 111(5). 548–559.
3.
Kozieł, Monika, Christine Teutsch, Jonathan L. Halperin, et al.. (2021). Atrial fibrillation and comorbidities: Clinical characteristics and antithrombotic treatment in GLORIA-AF. PLoS ONE. 16(4). e0249524–e0249524.
4.
Kozieł, Monika, Christine Teutsch, Shihai Lu, et al.. (2021). Changes in anticoagulant prescription patterns over time for patients with atrial fibrillation around the world. Journal of Arrhythmia. 37(4). 990–1006.
5.
Teutsch, Christine, Sérgio Dubner, Hans‐Christoph Diener, et al.. (2021). Anticoagulation Prescription and Outcomes in Relation to Renal Function in Patients with Atrial Fibrillation: Results from GLORIA-AF. SHILAP Revista de lepidopterología. 5(1). e35–e42.
6.
Shlyakhto, Е. V., S. V. Villevalde, Andrey Ezhov, et al.. (2020). Clinical performance of the atrial fibrillation in the Russian population depending on the antithrombotic therapy: findings from the GLORIA-AF registry phase 2. Russian Journal of Cardiology. 25(11). 4179–4179.
7.
Shlyakhto, Е. V., S. V. Villevalde, Andrey Ezhov, et al.. (2020). Clinical performance of the atrial fibrillation in the Russian population depending on the antithrombotic therapy: findings from the GLORIA-AF registry phase 2. SHILAP Revista de lepidopterología. 25(11). 4179–4179.
8.
Dubner, Sérgio, Christine Teutsch, Menno V. Huisman, et al.. (2020). Characteristics and 2-Year Outcomes of Dabigatran Treatment in Patients with Heart Failure and Atrial Fibrillation: GLORIA-AF. ESC Heart Failure. 7(5). 2679–2689.
9.
Boriani, Giuseppe, Menno V. Huisman, Christine Teutsch, et al.. (2020). Influence of BMI and geographical region on prescription of oral anticoagulants in newly diagnosed atrial fibrillation: The GLORIA-AF Registry Program. European Journal of Internal Medicine. 80. 35–44.
10.
Paquette, Miney, Lionel Riou França, Christine Teutsch, et al.. (2019). Dabigatran Persistence and Outcomes Following Discontinuation in Atrial Fibrillation Patients from the GLORIA-AF Registry. The American Journal of Cardiology. 125(3). 383–391.
11.
Mazurek, Michał, Christine Teutsch, Hans‐Christoph Diener, et al.. (2019). Safety and effectiveness of dabigatran at 2 years: Final outcomes from Phase II of the GLORIA-AF registry program. American Heart Journal. 218. 123–127.
12.
Mazurek, Michał, Menno V. Huisman, Kenneth J. Rothman, et al.. (2018). Gender Differences in Antithrombotic Treatment for Newly Diagnosed Atrial Fibrillation: The GLORIA-AF Registry Program. The American Journal of Medicine. 131(8). 945–955.e3.
13.
Paquette, Miney, Menno V. Huisman, G. Y. H. Lip, et al.. (2018). P4799When are atrial fibrillation patients at risk to discontinue anticoagulation treatment? Results from the GLORIA-AF Registry. European Heart Journal. 39(suppl_1).
14.
McIntyre, William F., David Conen, Brian Olshansky, et al.. (2018). Stroke‐prevention strategies in North American patients with atrial fibrillation: The GLORIA‐AF registry program. Clinical Cardiology. 41(6). 744–751.
15.
Dubner, Sérgio, Menno V. Huisman, Hans‐Christoph Diener, et al.. (2018). P2887Two-year outcomes of dabigatran etexilate treatment in patients with co-morbid heart failure and atrial fibrillation: the GLORIA-AF registry. European Heart Journal. 39(suppl_1).
16.
Lip, G Y H, Menno V. Huisman, Hans‐Christoph Diener, et al.. (2017). RATES OF STROKE AND BLEEDING WITH DABIGATRAN 150 AND 110 MG BID IN CLINICAL PRACTICE: THE GLORIA-AF REGISTRY. Journal of the American College of Cardiology. 69(11). 541–541.
17.
Paquette, Miney, Lionel Riou França, Christine Teutsch, et al.. (2017). Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation. Journal of the American College of Cardiology. 70(13). 1573–1583.
18.
McIntyre, William F., David Conen, Brian Olshansky, et al.. (2017). PREDICTORS OF ANTICOAGULANT PRESCRIPTION IN PATIENTS WITH ATRIAL FIBRILLATION IN NORTH AMERICA: THE GLORIA-AF REGISTRY. Journal of the American College of Cardiology. 69(11). 413–413.
19.
Paquette, Miney, Menno V. Huisman, Gregory Y.H. Lip, et al.. (2017). PERSISTENCE WITH THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION: THE GLORIA-AF REGISTRY. Journal of the American College of Cardiology. 69(11). 374–374.
20.
Huisman, Menno V., Kenneth J. Rothman, Miney Paquette, et al.. (2017). Two-year follow-up of patients treated with dabigatran for stroke prevention in atrial fibrillation: Global Registry on Long-Term Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) registry. American Heart Journal. 198. 55–63.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Anja Katholing Breakdown of academic impact, for papers by Gloria Kayani Breakdown of academic impact, for papers by Steve Deitelzweig Breakdown of academic impact, for papers by Lauren Uyeda Breakdown of academic impact, for papers by Peter J Svensson Breakdown of academic impact, for papers by Alan John Camm Breakdown of academic impact, for papers by Franziska Ebertz Breakdown of academic impact, for papers by Volkan Doğan Breakdown of academic impact, for papers by Gheorghe‐Andrei Dan Breakdown of academic impact, for papers by C.V. Damaraju